StockWatch
·
HomeLiveWeekly
Hospital
Quarterly Result19 Jan 2026, 11:40 am

Indraprastha Medical Corporation Ltd to Approve Q3 and Nine Months Financial Results on Feb 34, 2026

AI Summary

Indraprastha Medical Corporation Ltd has announced that its Board of Directors will meet on February 34, 2026, to consider and approve the unaudited financial results for the quarter and nine months ended 31st December, 2025. This is in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Highlights

  • Indraprastha Medical Corporation Ltd to hold a Board Meeting on Feb 34, 2026
  • The meeting will consider and approve the unaudited financial results for the quarter and nine months ended 31st December, 2025
View BSE Filing
INDRAMEDCO
Hospital
INDRAPRASTHA MEDICAL CORP.LTD.

Price Impact

More from INDRAMEDCO

Board Meeting2h ago

Indraprastha Medical Board Meeting on Aug 6 to Approve Q1 FY27 Results

Insider Trading24 Jun, 5:10 pm

Indraprastha Medical Trading Window Closed for Insider Trading

Dividend12 May, 5:51 pm

Indraprastha Medical Corp Recommends ₹4 Dividend

More in Quarterly Result

SENORES39m ago

Senores Pharma Q1 FY27 Revenue Up 36% to ₹180 Cr

PANCM52m ago

Panyam Cements Declares FY26 Audited Results, Reports Net Loss

NELCAST57m ago

Nelcast Ltd Reports Q1 FY27 Results; Revenue Up 2.8%